HeartCare Articles. Save. Your. Heart.

Statewide Poll Shows Significant Majority Of Georgians Support Embryonic Stem Cell Research And Therapeutic Cloning

March 11, 2017

A statewide poll conducted on behalf of the Georgia Biomedical Partnership demonstrates that a significant majority of Georgia registered voters supports embryonic stem cell research and therapeutic cloning. The poll also shows Georgians overwhelmingly oppose reproductive cloning.

The poll was conducted by Republican pollster and public affairs researcher Dr. Whit Ayres of Ayres McHenry & Associates, Inc., based in Washington, DC. Dr. Ayres has worked as a pollster for Senate Majority Leader Bill Frist and Senators Lamar Alexander, Lindsey Graham, and the late Paul Coverdell.

The results show that Georgia voters by a more than two-to-one margin (67% to 31%) support embryonic stem cell research and by a double digit margin (55% to 42%) support therapeutic cloning. Voters overwhelmingly oppose reproductive cloning by a 79% to 16% margin.

In addition, two-thirds of Georgia voters believe that any medical research allowed by federal law should be allowed in Georgia; and three- fourths believe that new treatments derived from embryonic stem cell research done outside the state should be allowed in Georgia.

"These findings clearly demonstrate the vast majority of Georgians embrace the potential of medical research, including embryonic stem cell research, to improve their quality of life," said Georgia Biomedical Partnership President Charles Craig. "The results show that Georgia voters support the state's robust biosciences industry as a major driver of improved health and economic growth. The poll also strongly suggests Georgia voters would oppose attempts to ban or criminalize stem cell research."

The Georgia Biomedical Partnership is a private, non-profit association representing 280 pharmaceutical, biotechnology, and medical device companies, universities, research institutes, government groups and other bioscience- related businesses and organizations.

Georgia Biomedical Partnership
gabio/